Nurse Anesthetist - CR in Spencer, IA Accepting Medicare

10 Nurse Anesthetist - CR nurses found. Showing 1 - 10

Sheri Ann Baker, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1200 1st Ave E, Spencer, IA 51301 Phone: 912-264-6198

Benjamin John Armstrong, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1200 1st Ave E, Spencer, IA 51301 Phone: 712-264-6165

Eric Wayne Anderson, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1200 1st Ave E, Spencer, IA 51301 Phone: 952-442-9770

John Anthon Haak, CRNA, ARNP Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1200 1st Ave E, Spencer, IA 51301 Phone: 712-264-6164

Richard Mishler, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1200 1st Ave E, Spencer, IA 51301 Phone: 952-442-9770

Dale Kroll, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1200 1st Ave E, Spencer, IA 51301 Phone: 952-442-9770

Natasha Jean Broom, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1200 1st Ave E, Spencer, IA 51301 Phone: 712-264-6198

Larry Westphal, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 1200 1st Ave E, Spencer, IA 51301 Phone: 952-442-9770

Keith E Begeman, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1200 1st Ave E, Spencer, IA 51301 Phone: 712-264-8300    Fax: 952-442-3620

Robert Appel, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 1200 1st Ave E, Spencer, IA 51301 Phone: 952-442-9770

News Archive

U.S. Food and Drug Administration approves new genetic breast cancer test

The U.S. Food and Drug Administration has approved a test that helps in assessing the risk of tumor recurrence and long-term survival for patients with relatively high-risk breast cancer. The TOP2A FISH pharmDx is the first approved device to test for the TOP2A (topoisomerase 2 alpha) gene in cancer patients.

Study confirms rare blood clotting risk linked to ChAdOx1-S vaccine - benefits still outweigh risks

New research published in BMJ confirmed evidence of blood clotting finding a small risk after receiving one Oxford-AstraZeneca ChAdOx1-S severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine.

Synthetic Biologics prices underwritten public offering of common stock at $1.00 per share

Synthetic Biologics, Inc., a developer of product candidates focused on the prevention and treatment of serious infectious and other diseases, announced today the pricing of an underwritten public offering of 11,500,000 shares of common stock at a public offering price of $1.00 per share.

American Society of Anesthesiologists announces recognition of Patient Safety Awareness Week

The American Society of Anesthesiologists (ASA) today announced its recognition of Patient Safety Awareness Week, March 3-9, 2013. Throughout the week, ASA will educate patients on the importance of physician-led care to make critical, life-saving decisions.

Niiki Pharma announces positive data from ongoing trial of novel anti-cancer agent NKP-1339

Niiki Pharma Inc. announced interim results from the ongoing Phase I clinical trial of its lead product, NKP-1339. NKP-1339 is a first-in-class transferrin targeted small molecule that down-regulates GRP78, a key regulator of mis-folded protein processing and a tumor survival factor.

Read more Medical News

› Verified 4 days ago